Media Coverage
Mark Edinger | September 27, 2018

Significant Developments, Trends and Approaches in Next Generation Flow Cytometry

Q&A with Mark Edinger
Flow cytometry has gone through many changes in the past decades, and it continues to gain greater utility in drug development testing for pharmaceutical and biotechnology companies. The usage of flow cytometry has had recent advances in complexity, including flow cytometry instrument designs, reagents, and analysis algorithms.

Mark Edinger, scientific affairs director of flow cytometry, was interviewed by Applied Clinical Trials, where he discussed trends in next generation flow cytometry. Read the article to learn how flow cytometry has become a central part of the development of new immunotherapies, and how next generation flow cytometry will become an even more essential tool in discovery as it continues to expand its capability and utility.

Related Services:
Global Flow Cytometry Services

Unique global flow cytometry services are designed to meet your clinical trial needs

Next Generation Flow Cytometry

25th International Molecular Medicine Tri Conference

Validating Flow Cytometry Assays for Immuno-Oncology Trials in the Central Lab

Molecular Medicine Tri-Conference 2017

Q2 Solutions Central Laboratory Services

Optimized logistics, deeper science, better insights

Read More